Comparing the Prognostic Value of Risk stratifying Models for Patients with Lower-Risk Myelodysplastic Syndromes: Is one model better?

  • Comparing risk-stratification tools for lower-risk MDS patients
  • Amer M Zeidan, Mikkael A. Sekeres, Xiao-Feng Wang, Najla Al Ali, Guillermo Garcia-Manero, David P. Steensma, Gail Roboz, John Barnard, Eric Padron, Amy Dezern, Jaroslaw P. Maciejewski, Alan F List, Rami S Komrokji
  • American Journal of Hematology, August 2015, Wiley
  • DOI: 10.1002/ajh.24170

The authors haven't yet claimed this publication.

Read Publication

In partnership with:

Link to Wiley showcase